Generation X Experiencing Larger Per-Capita Increases in Cancer Incidence

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on June 12, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, June 12, 2024 -- Generation X is experiencing larger per-capita increases in the incidence of cancers than Baby Boomers, according to a study published online June 10 in JAMA Network Open.

Philip S. Rosenberg, Ph.D., and Adalberto Miranda-Filho, Ph.D., from the National Cancer Institute in Bethesda, Maryland, estimated invasive cancer incidence trends in successive generations. Stratum-specific semiparametric age-period-cohort models were fitted and incidence was calculated per 100,000 person-years at the reference age of 60 years for single-year birth cohorts from 1908 through 1983 (fitted cohort patterns [FCPs]). The FCPs and FCP incidence rate ratios [IRRs] were compared for Generation X (born 1965 to 1980) and Baby Boomers (born 1946 to 1964).

The analysis included 3.8 million individuals with invasive cancer. The researchers found that the FCP IRRs among women were significantly increased for thyroid, kidney, rectal, corpus uterine, colon, and pancreatic cancers, non-Hodgkin lymphoma, and leukemia in Generation X versus Baby Boomers (FCP IRRs, 2.76, 1.99, 1.84, 1.75, 1.56, 1.39, 1,40, and 1.27, respectively). Among men, increases were seen for thyroid, kidney, rectal, colon, and prostate cancers and leukemia (2.16, 2.14, 1.80, 1.60, 1,25, and 1.34, respectively). Among women, decreases were seen in lung and cervical cancer incidence (IRRs, 0.60 and 0.71, respectively), while among men, decreases were seen in lung, liver, and gallbladder cancer and non-Hodgkin lymphoma (IRRs, 0.51, 0.76, 0.85, and 0.75, respectively). Increases in the incidence of cancers numerically overtook decreasing incidence in all groups except Asian or Pacific Islander men, resulting in higher FCPs in Generation X than Baby Boomers for all cancers combined.

"If the Millennials' cancer experience follows the estimated trajectory of their proxy parents, cancer incidence in the U.S. could remain unacceptably high for decades to come," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-13 05:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords